Development of WHO Recommended Therapeutic Practices (RTP) for the prevention and treatment of preeclampsia and premature birth
2022 - 2023
Period: 2022 – 2023
Researchers
Dr. Veronica Pingray
Dr. Mabel Berrueta
Dr. Karen Klein
Dr. Vanesa Ortega
Agustina Villarejo, Esq.
Objective
Develop 4 Target Product Profiles (TPP) for the prevention and management of preeclampsia and spontaneous preterm birth, for the World Health Organization (WHO) that guide researchers, funders and product developers towards innovative treatments that respond to these maternal and perinatal health needs.
Type of study
Expert consensus/public consultation
Finance
WHO

